<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04525027</url>
  </required_header>
  <id_info>
    <org_study_id>EC/12/19/1650</org_study_id>
    <nct_id>NCT04525027</nct_id>
  </id_info>
  <brief_title>Predictive Ability of Intra-Abdominal Pressure for Mortality in Patients With Severe Acute Pancreatitis</brief_title>
  <official_title>Predictive Ability of Intra-Abdominal Pressure for Mortality in Patients With Severe Acute Pancreatitis: A Prospective Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Postgraduate Institute of Medical Education and Research</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sir Ganga Ram Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Postgraduate Institute of Medical Education and Research</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Severe Acute Pancreatitis (SAP) is an acute inflammatory condition of the pancreas&#xD;
      characterized by organ dysfunction and increased mortality. Increased Intra-abdominal&#xD;
      Pressure(IAP) in SAP is a result of inflammation of pancreatic and peripancreatic tissue,&#xD;
      aggressive fluid resuscitation and increased capillary permeability, which is associated with&#xD;
      organ dysfunction, by limiting the vascular supply to the tissue. Abdominal Compartment&#xD;
      Syndrome (ACS) is defined as IAP greater than 20 mm of Hg and is considered an abdominal&#xD;
      catastrophe. Intra-abdominal Hypertension (IAH, Intra-abdominal pressure &gt; 12mm of Hg), may&#xD;
      contribute to early organ dysfunction, ACS and eventually hemodynamic collapse if left&#xD;
      untreated. This signifies the need for determining the burden of the condition and&#xD;
      identifying the high risk patient group who are prone to develop IAH /ACS and predicting&#xD;
      mortality associated with the condition. Measurement of IAP will be done indirectly by&#xD;
      measuring intravesicular pressure using modified kron's method. IAP will be measured at the&#xD;
      time of admission into Intensive Care Unit (ICU) and every day thereafter during the initial&#xD;
      five days of ICU admission. Any reading of IAP â‰¥12 mm of Hg shall be considered as IAH. SOFA&#xD;
      and APACHE II score will be noted on the day of admission in the ICU. Any interventions,&#xD;
      surgical or non surgical as per clinician's decision will be recorded. The patients will be&#xD;
      followed up until discharge or mortality until 30 days. The proposed study aims to assess the&#xD;
      predictive ability of IAP during the first 5 days of ICU admission for predicting mortality&#xD;
      in patients with SAP. Prediction accuracy will also be compared with SOFA and APACHE II&#xD;
      scores.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 26, 2019</start_date>
  <completion_date type="Anticipated">January 25, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 25, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>30 days from inclusion date</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">360</enrollment>
  <condition>Acute Pancreatitis</condition>
  <condition>Intra-Abdominal Hypertension</condition>
  <arm_group>
    <arm_group_label>survivors</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>non survivors</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>intra-abdominal pressure in severe acute pancreatitis</intervention_name>
    <description>daily intra abdominal pressures in patients admitted to ICU will be measured and noted for intial 5 days and followed up until end outcome</description>
    <arm_group_label>non survivors</arm_group_label>
    <arm_group_label>survivors</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients of acute severe pancreatitis admitted to ICU within 72 hours of symptom onset&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        &gt;Patients with severe acute pancreatitis in the age group of 18-65 years admitted to ICU&#xD;
        within 72 hours of onset of symptoms&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Previous history of any abdominal or pelvic surgery&#xD;
&#xD;
          -  Known case of bladder tumor or bladder abnormality.&#xD;
&#xD;
          -  Difficulty in urinary catheterization&#xD;
&#xD;
          -  Use of neuromuscular blockade&#xD;
&#xD;
          -  Pregnant patients&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>vinod singh, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Sir Ganga Ram Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>vamsidhar amburu, MD</last_name>
    <phone>+919814866818</phone>
    <email>rahdismav_a@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sir Ganga Ram Hospital</name>
      <address>
        <city>New delhi</city>
        <state>Delhi</state>
        <zip>110060</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>vamsidhar Amburu</last_name>
      <phone>+919814866818</phone>
      <email>vamsidharlive@live.com</email>
    </contact>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>August 18, 2020</study_first_submitted>
  <study_first_submitted_qc>August 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 24, 2020</study_first_posted>
  <last_update_submitted>August 21, 2020</last_update_submitted>
  <last_update_submitted_qc>August 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sir Ganga Ram Hospital</investigator_affiliation>
    <investigator_full_name>VAMSIDHAR</investigator_full_name>
    <investigator_title>Trainee</investigator_title>
  </responsible_party>
  <keyword>severe acute pancreatitis</keyword>
  <keyword>intra abdominal pressure</keyword>
  <keyword>mortality</keyword>
  <keyword>intra abdominal hypertension</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intra-Abdominal Hypertension</mesh_term>
    <mesh_term>Pancreatitis</mesh_term>
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

